Zika Virus Testing Market Size To Reach $341.6 Million By 2030

Zika Virus Testing Market Growth & Trends

The global zika virus testing market size is expected to reach USD 341.6 million by 2030, according to a new report by Grand View Research, Inc., progressing at a CAGR of 7.3% from 2024 to 2030. Zika virus outbreak in 2016 contributed to the rise in response strategies and diagnostic surveillance activities. Widespread incidence of the disease in 2016 was mostly a result of travel-based viral transmission. The recently drawn correlation between Zika virus infection and microcephaly in newborns is further stoking growth of the market. 

Spiraling demand for Zika Virus Testing stems from government-led preparedness programs and support from international organizations such as UNICEF. Stockpiling and emergency preparedness initiatives focus on endemic regions as well as immunologically naïve population subsets in the Asian and African markets, which hold high threat of future outbreaks. These developing regions, currently not classified as endemic, are host to temperature changes, humidity, and precipitation as well as reported vector presence that cumulatively provide a supportive habitat for the causative vector, Aedes aegypti mosquitoes.

 Request a free sample copy or view report summary: Zika Virus Testing Market Report

Zika Virus Testing Market Report Highlights

• The serological test dominated the market and accounted for the largest revenue share of 51.1% in 2023.

• Molecular tests are expected to grow at a CAGR of 8.8% over the forecast period attributed to the continuous advancements in molecular diagnostic technologies, such as polymerase chain reaction (PCR) and nucleic acid amplification.

• Clinical laboratories led the market and accounted for the largest revenue share of 47.4% in 2023.

• Hospitals are expected to grow at a CAGR of 7.3% over the forecast period attributed to the rising demand for diagnosis and treatment of Zika virus and the high need for accurate and quick tests.

Zika Virus Testing Market Segmentation

Grand View Research has segmented the global zika virus testing market on the basis of test, end use, and region:

Zika Virus Testing Test Outlook (Revenue, USD Million, 2018 - 2030)

• Molecular Test

• Serological Test

Zika Virus Testing End use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals/Clinics

• Diagnostic Laboratory

• Others

Zika Virus Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S. States

  • U.S. Territories

• Europe

  • Continental Europe

  • Caribbean(EU)

• Asia Pacific

  • Singapore

  • Vietnam

  • Indonesia

  • Thailand

• Latin America

  • Brazil

  • Colombia

• Middle East and Africa (MEA)

  • South Africa

List of Key Players of Zika Virus Testing Market

• Abbott

• DiaSorin S.p.A.

• F. Hoffmann-La Roche Ltd.

• Quest Diagnostics Incorporated

• Siemens Healthineers AG

• Chembio Diagnostic Systems, Inc.

• SD Biosensors, Inc.

• Biocan Diagnostics

• ARUP Laboratories

• Viatris Inc.